Femoral nerve block

Surgical approach (where this block is used)

  • Not an operation itself; commonly used as analgesia/anaesthesia for surgery involving the anterior thigh and knee.
  • Typical operations where femoral nerve block (FNB) may be requested/used
    • Femoral shaft fracture fixation / traction / splintage (analgesia in ED/trauma)
    • Knee surgery: arthroscopy, ACL reconstruction (often combined with other blocks), patella surgery
    • Total knee arthroplasty (increasingly adductor canal block preferred for motor-sparing; FNB still relevant)
    • Skin grafting / wound care to anterior thigh

Anaesthetic management (typical context)

  • Type of anaesthesia
    • Regional analgesia adjunct to GA for knee/thigh surgery; or standalone block for analgesia (e.g., femoral fracture) with/without light sedation.
    • If used as sole anaesthetic for surgery: usually requires additional blocks (e.g., sciatic/obturator/lateral femoral cutaneous) depending on procedure.
  • Airway
    • If GA: SGA often suitable for short knee arthroscopy; ETT for longer/complex surgery, aspiration risk, positioning, or need for paralysis.
    • If block + sedation: maintain spontaneous ventilation; be prepared to convert to GA if inadequate block or agitation/pain.
  • Duration
    • Block performance: typically 5–15 min; onset 10–30 min (agent dependent).
    • Analgesia duration: ~6–18 h (single-shot; depends on LA choice/adjuncts). Continuous catheter can provide days.
  • How painful is the surgery?
    • Femoral fracture and knee surgery can be very painful; multimodal analgesia usually required.
    • FNB covers anterior knee/anterior thigh well but does not reliably cover posterior knee pain (often sciatic contribution).
  • Key perioperative considerations
    • Motor weakness (quadriceps) → falls risk; mobilise with caution and document advice.
    • Anticoagulation status and infection risk (particularly for catheter techniques).
    • Local anaesthetic systemic toxicity (LAST) risk: calculate maximum dose; incremental injection with aspiration; consider ultrasound guidance.

Overview

  • Femoral nerve block provides analgesia/anaesthesia to the anterior thigh and much of the anterior knee; also contributes to medial leg/foot via saphenous nerve (terminal sensory branch).
  • Common uses: analgesia for femoral fractures; perioperative analgesia for knee surgery; can be part of combined blocks for more extensive lower limb surgery.

Applied anatomy (high yield)

  • Origin and course
    • Lumbar plexus: posterior divisions of L2–L4 (sometimes L1 contribution).
    • Emerges lateral to psoas major, runs between psoas and iliacus, passes under inguinal ligament into femoral triangle.
  • Relations in femoral triangle (classic exam anatomy)
    • Lateral to femoral artery; outside femoral sheath (artery/vein within sheath; nerve outside).
    • Order lateral → medial: femoral Nerve, Artery, Vein, (empty space), Lymphatics ("NAVeL").
    • Often lies beneath fascia iliaca; fascia lata is more superficial.
  • Branches and sensory/motor supply (what it covers)
    • Motor: quadriceps femoris (knee extension), sartorius, pectineus (variable).
    • Sensory: anterior thigh (anterior cutaneous branches); medial leg/ankle/foot via saphenous nerve; articular branches to hip and knee.
    • Does NOT reliably cover: lateral thigh (lateral femoral cutaneous nerve), posterior knee (sciatic), medial thigh (obturator).

Indications

  • Analgesia for femoral shaft/neck fractures (often as part of fascia iliaca compartment block pathway; FNB is a targeted alternative).
  • Perioperative analgesia for knee surgery (arthroscopy, ligament reconstruction, patella surgery, TKA—though adductor canal block often preferred for mobilisation).
  • Analgesia for anterior thigh procedures (skin graft donor site).
  • Diagnostic/therapeutic pain interventions (less common in FRCA context).

Contraindications

  • Absolute
    • Patient refusal / lack of capacity without appropriate best-interest decision.
    • Allergy to local anaesthetic (true IgE-mediated rare; clarify reaction).
    • Infection at injection site.
  • Relative / caution
    • Anticoagulation/bleeding diathesis: peripheral nerve blocks generally lower risk than neuraxial, but femoral region is non-compressible deep to fascia; consider haematoma risk and local policy/ASRA/RA-UK guidance.
    • Pre-existing femoral neuropathy or significant peripheral neuropathy (risk of attribution/worsening).
    • Severe sepsis/haemodynamic instability (risk–benefit; may still be appropriate for analgesia but ensure resuscitation and monitoring).
    • Inability to cooperate/position safely (consider sedation/GA or alternative technique).

Preparation and monitoring (OSCE/viva structure)

  • Consent: purpose, expected benefits, alternatives (systemic opioids, fascia iliaca block, adductor canal block), and specific risks.
  • Monitoring: standard AAGBI monitoring; IV access; resuscitation equipment and intralipid immediately available.
  • Asepsis: full barrier precautions for catheter; at least sterile gloves, skin prep, sterile probe cover/gel for ultrasound.
  • Local anaesthetic safety: calculate maximum safe dose (consider lean body weight, age, frailty); use incremental injection with frequent aspiration; consider using lower concentration/volume when appropriate.

Techniques

  • Approaches
    • Ultrasound-guided (preferred): direct visualisation of nerve, artery, fascia; lower vascular puncture and potentially lower LA volume.
    • Nerve stimulator (landmark-based): relies on motor response (quadriceps/patellar twitch).
    • Landmark/paresthesia techniques: less favoured due to higher failure/complication risk.
  • Ultrasound anatomy (transverse at inguinal crease)
    • Femoral artery: pulsatile anechoic circle; femoral vein medial and compressible.
    • Femoral nerve: hyperechoic, triangular/oval structure lateral to artery, under fascia iliaca, superficial to iliopsoas.
    • Fascia lata (superficial) and fascia iliaca (deeper) appear as hyperechoic lines; aim to deposit LA under fascia iliaca around nerve.
  • Ultrasound-guided steps (in-plane lateral-to-medial typical)
    • Position: supine, leg slightly abducted and externally rotated; expose groin; identify landmarks and scan.
    • Needle: in-plane, advance towards lateral aspect of nerve; avoid intraneural injection (high resistance, nerve swelling, pain/paresthesia).
    • Hydrodissection with small aliquots to confirm correct plane under fascia iliaca; then inject incrementally to surround nerve (circumferential spread desirable but not always necessary).
    • Aspirate every 3–5 mL; observe spread; reassess needle tip frequently.
  • Nerve stimulator technique (key points)
    • Needle inserted 1–2 cm lateral to femoral artery at inguinal crease; seek quadriceps contraction/patellar twitch.
    • Typical stimulator settings: start 1.0 mA, 0.1 ms, 2 Hz; acceptable response at ~0.2–0.5 mA suggests close proximity (avoid <0.2 mA with strong response—possible intraneural).
    • Inject after negative aspiration; stop if severe pain/paresthesia or high resistance.
  • Catheter technique (continuous femoral nerve block)
    • Indications: major knee surgery (e.g., TKA) where prolonged analgesia desired; consider motor weakness vs adductor canal catheter alternative.
    • Thread catheter 3–5 cm beyond needle tip under ultrasound; secure well; label catheter; prescribe infusion with clear limits and monitoring plan.

Local anaesthetic choice and dosing (typical ranges; tailor to patient)

  • Single-shot volumes commonly 10–20 mL with ultrasound (higher volumes may be used with landmark techniques but increase LAST risk).
  • Agents
    • Lidocaine 1–2%: faster onset, shorter duration.
    • Bupivacaine 0.25–0.5% or levobupivacaine 0.25–0.5%: longer duration.
    • Ropivacaine 0.2–0.5%: long-acting with relatively less motor block at lower concentrations (still causes quadriceps weakness with FNB).
  • Adjuncts (departmental policy dependent)
    • Dexamethasone (perineural or IV) may prolong duration; consider infection risk, hyperglycaemia, and local governance.
    • Clonidine may prolong block but can cause hypotension/sedation.

Block assessment and expected effects

  • Sensory: reduced cold/pinprick anterior thigh and medial leg (saphenous).
  • Motor: reduced knee extension (quadriceps) and reduced patellar reflex.
  • Analgesic limitations: persistent posterior knee pain suggests sciatic contribution; lateral thigh pain suggests lateral femoral cutaneous nerve; medial thigh pain suggests obturator.

Complications and management

  • Block failure / incomplete block
    • Causes: wrong plane (above fascia iliaca), inadequate volume, anatomical variation, intravascular uptake, time insufficient for onset.
    • Management: reassess clinically and with ultrasound; consider top-up/repeat with safe dosing; supplement with additional blocks or systemic analgesia; convert to GA if required.
  • Vascular puncture / haematoma
    • Avoid: ultrasound identification of artery/vein, in-plane visualisation, aspiration, gentle technique.
    • Manage: direct pressure, reassess anticoagulation, document; consider imaging/surgical review if expanding haematoma or neurovascular compromise.
  • Local anaesthetic systemic toxicity (LAST)
    • Early features: tinnitus, metallic taste, circumoral numbness, agitation, seizures; later: arrhythmias, cardiovascular collapse.
    • Immediate management: stop injection, call for help, airway/oxygen/ventilation, treat seizures (benzodiazepine), start intralipid per guidelines, manage arrhythmias (avoid large doses of propofol in unstable patient; avoid vasopressin; use reduced-dose adrenaline).
  • Nerve injury
    • Mechanisms: intraneural injection, needle trauma, ischaemia/haematoma, neurotoxicity, stretch/compression.
    • Prevention: avoid paresthesia/pain on injection, avoid high opening pressure, keep needle tip in view, use minimal effective dose, avoid deep sedation during injection so patient can report symptoms.
    • If suspected: stop, document, examine and follow local nerve injury pathway; early neurology referral if severe/progressive deficit.
  • Infection (esp. catheter)
    • Asepsis, secure dressing, daily review; remove catheter if signs of infection or unexplained sepsis.
  • Falls due to quadriceps weakness
    • Warn patient and staff; physiotherapy precautions; consider knee brace if mobilising; consider adductor canal block as alternative for motor-sparing knee analgesia.

Comparisons and related blocks (common viva angles)

  • Femoral nerve block vs fascia iliaca compartment block (FICB)
    • FNB: targeted block of femoral nerve; reliable quadriceps weakness; good anterior thigh/knee analgesia.
    • FICB: aims to block femoral + lateral femoral cutaneous ± obturator by high-volume spread under fascia iliaca; often used in ED/trauma pathways; may be less reliable for obturator.
  • Femoral nerve block vs adductor canal block (ACB)
    • ACB targets saphenous nerve/nerve to vastus medialis in adductor canal → better motor preservation for mobilisation after knee surgery, but may provide less analgesia than FNB for some procedures.

Documentation (often examined in OSCE)

  • Record: indication, side, technique (US/NS), asepsis, LA drug/concentration/volume, adjuncts, needle/catheter details, complications, block assessment, advice re falls, and post-block monitoring plan.
Describe the anatomy relevant to a femoral nerve block at the inguinal crease.

Aim for relations, fascial planes, and what structures are in the femoral sheath.

  • Femoral nerve arises from posterior divisions of L2–L4 and enters the femoral triangle under the inguinal ligament.
  • In the femoral triangle, the nerve lies lateral to the femoral artery and outside the femoral sheath.
  • Femoral sheath contains artery and vein (and lymphatics medially) but not the nerve.
  • Fascial layers: fascia lata superficial; fascia iliaca deeper—femoral nerve lies beneath fascia iliaca on iliopsoas.
What areas are anaesthetised by a femoral nerve block, and what areas are not covered?

Examiners want clear dermatomal/territorial coverage and limitations for knee surgery.

  • Covers: anterior thigh (anterior cutaneous branches), anterior knee (articular branches), medial leg/ankle/foot via saphenous nerve.
  • Motor: quadriceps weakness (knee extension) and reduced patellar reflex.
  • Does not reliably cover: posterior knee (sciatic), lateral thigh (lateral femoral cutaneous), medial thigh/adductor region (obturator).
Talk me through how you would perform an ultrasound-guided femoral nerve block safely.

Structure: preparation → scanning → needle approach → injection safety → post-block care.

  • Preparation: consent, check anticoagulation/infection, IV access, monitoring, intralipid available, full asepsis and sterile ultrasound setup.
  • Scan at inguinal crease: identify femoral artery, vein (medial), and femoral nerve (hyperechoic lateral) under fascia iliaca on iliopsoas.
  • Needle in-plane (often lateral-to-medial) with tip visualised at all times; aim to place tip just under fascia iliaca adjacent to nerve.
  • Inject incrementally with aspiration every 3–5 mL; observe spread around nerve; stop if pain/paresthesia, high resistance, or nerve swelling.
  • Post-block: assess sensory/motor effect, document, and give falls precautions due to quadriceps weakness.
How would you use a nerve stimulator to perform a femoral nerve block? What response are you looking for and at what current?

Key points: insertion point, motor response, safe current threshold, and what to avoid.

  • Insert needle 1–2 cm lateral to femoral artery at inguinal crease; advance until quadriceps contraction/patellar twitch seen.
  • Start around 1.0 mA, 0.1 ms, 2 Hz; reduce current—acceptable response typically at ~0.2–0.5 mA.
  • Avoid injecting if response persists at very low current (<0.2 mA) with strong twitch (possible intraneural) or if injection is painful/high resistance.
A patient still has severe posterior knee pain after a femoral nerve block for knee surgery. Why, and what would you do?

This is a common FRCA viva scenario: recognise incomplete coverage and propose a safe plan.

  • Reason: posterior knee pain is commonly supplied by sciatic nerve branches; femoral block mainly covers anterior knee.
  • Assess: confirm block success (anterior thigh/knee sensation and quadriceps weakness), check surgical site and tourniquet pain, consider opioid requirement.
  • Management options: supplement analgesia (paracetamol/NSAID if appropriate, opioids), consider additional regional technique (e.g., sciatic block or IPACK depending on setting/skills), or convert to GA if intraoperative pain.
List the complications of femoral nerve block and how you would minimise them.

Examiners want: vascular puncture, LAST, nerve injury, infection (catheter), and falls.

  • Vascular puncture/haematoma: ultrasound identification, in-plane technique, aspiration, avoid multiple passes; apply pressure if puncture occurs.
  • LAST: dose calculation, incremental injection, aspiration, ultrasound guidance; immediate recognition and intralipid-based resuscitation.
  • Nerve injury: avoid intraneural injection, avoid high pressure/pain on injection, keep patient responsive enough to report symptoms, visualise needle tip.
  • Infection (catheter): strict asepsis, secure dressing, daily review, timely removal.
  • Falls: warn patient/staff, physiotherapy precautions, consider motor-sparing alternatives (adductor canal block) when appropriate.
Discuss local anaesthetic choice and volume for femoral nerve block, and how you ensure safe dosing.

They want principles rather than a single recipe: minimum effective volume, patient factors, and total dose across multiple blocks.

  • Choose LA based on desired onset/duration: lidocaine for rapid onset; bupivacaine/levobupivacaine/ropivacaine for prolonged analgesia.
  • Typical ultrasound-guided volume 10–20 mL; use the minimum effective volume to reduce LAST risk.
  • Calculate maximum safe dose considering weight, age, frailty, comorbidities, and total dose if combining blocks; inject incrementally with aspiration and monitoring.
How does femoral nerve block compare with fascia iliaca compartment block for hip/femoral fracture analgesia?

A frequent FRCA theme: compare targets, reliability, and practicalities in ED/trauma.

  • FNB: targeted femoral nerve block; reliable for femoral nerve territory; requires accurate placement near nerve; causes quadriceps weakness.
  • FICB: high-volume injection under fascia iliaca aiming to block femoral + lateral femoral cutaneous ± obturator; often used in ED pathways; obturator block is variable.
  • Both reduce opioid requirements and improve comfort for positioning/spinal anaesthesia; choice depends on local expertise, equipment, and desired nerve coverage.
A patient becomes agitated and then has a seizure shortly after you inject local anaesthetic for a femoral nerve block. What is your diagnosis and immediate management?

This is a classic crisis viva: treat as LAST until proven otherwise.

  • Diagnosis: local anaesthetic systemic toxicity (LAST).
  • Immediate actions: stop injection, call for help, maintain airway and give 100% oxygen, support ventilation to avoid acidosis.
  • Treat seizure: benzodiazepine (e.g., midazolam); avoid large propofol doses if cardiovascular instability.
  • Start lipid emulsion therapy per guideline; manage arrhythmias/cardiovascular collapse with modified ACLS (small adrenaline doses; avoid vasopressin).
  • Post-event: ICU/HDU monitoring, document, report, and counsel patient.
What advice would you give regarding mobilisation after a femoral nerve block?

This often appears as a safety/quality question.

  • Warn that quadriceps weakness can occur and increases falls risk; patient should mobilise only with assistance until strength returns.
  • Communicate with nursing/physio staff; consider mobility aids or knee brace if appropriate; document advice clearly.

0 comments